Dynavax to Present at the Wedbush 2011 Life Sciences Conference
BERKELEY, CA, Aug 11, 2011 (MARKETWIRE via COMTEX) -- Dynavax Technologies
Corporation (DVAX) announced today that it plans to present at the Wedbush 2011
Life Sciences Conference in New York on Wednesday, August 17, 2011 at 10:00 am
EDT (1:00 pm PDT).
Brant Biehn, Chief Commercial Officer of Dynavax, and Shari Annes, Investor
Relations of Dynavax, will provide a corporate overview presentation. To access
the live webcast and the subsequent archived recording of the presentation,
please log onto Dynavax's website at investors.dynavax.com.
About Dynavax
Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company,
discovers and develops novel products to prevent and treat infectious and
inflammatory diseases. The Company's lead product candidate is HEPLISAV(TM), a
Phase 3 investigational adult hepatitis B vaccine designed to provide rapid and
superior protection with fewer doses than current licensed vaccines. For more
information visit dynavax.com.
Contact:
Shari Annes
Investor Relations
510-665-7211
Email Contact |
